Human RAB11FIP4 activation kit by CRISPRa

CAT#: GA113546

RAB11FIP4 CRISPRa kit - CRISPR gene activation of human RAB11 family interacting protein 4



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
RAB11FIP4 mouse monoclonal antibody, clone OTI13B5 (formerly 13B5)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


RAB11FIP4 (Myc-DDK-tagged)-Human RAB11 family interacting protein 4 (class II) (RAB11FIP4)
    • 10 ug

CNY 4,744.00


RAB11FIP4 mouse monoclonal antibody, clone OTI13B5 (formerly 13B5)
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol RAB11FIP4
Locus ID 84440
Kit Components

GA113546G1, RAB11FIP4 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA113546G2, RAB11FIP4 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA113546G3, RAB11FIP4 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001303542, NM_032932, NM_001346747, NM_001346748, NM_001346749
Synonyms RAB11-FIP4
Summary The protein encoded by this gene interacts with RAB11 and is thought to be involved in bringing recycling endosome membranes to the cleavage furrow in late cytokinesis. Hypoxic conditions can lead to an upregulation of the encoded protein and enhance the metastatic potential of hepatocellular carcinoma. [provided by RefSeq, Oct 2016]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...